Abstract
Treatment of patients with oncopathology may be accompanied by a large number of adverse reactions, the most common symptoms of damage to the gastrointestinal tract (GIT) as development of mucositis. This condition significantly complicates the treatment of such patients due to an increase in the duration of hospitalization, the need to interrupt the course of chemotherapy, the need for additional nutritional support, symptomatic drug therapy and a significant deterioration in the quality of life. The presented clinical case demonstrates the possibility of using an enteroprotective combination of SES (saline enteral solution) + VERIS (Pectin+Inulin) as an additional therapy in order to reduce the severity of mucosal lesions Gastrointestinal tract on the background of chemoradiotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
